Samuel N. Hazen - 03 Feb 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: CEO, Director
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 03 Feb 2023
Net transactions value: -$4,243,601
Form type: 4
Filing time: 07 Feb 2023, 17:40:52 UTC
Previous filing: 01 Feb 2023
Next filing: 22 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Options Exercise	$4,068,640	+59,000	+75%	$68.96	137,885	03 Feb 2023	Direct
transaction	HCA	Common Stock	Tax liability	$8,312,241	-32,208	-23%	$258.08	105,677	03 Feb 2023	Direct
holding	HCA	Common Stock						813,320	03 Feb 2023	By LP
holding	HCA	Common Stock						300,000	03 Feb 2023	By 2022 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HCA	Stock Appreciation Right	Options Exercise	$0	-59,000	-100%	$0.000000^*	0	03 Feb 2023	Common Stock	59,000	$68.96	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016.